Treatment Interruptions and Associated Factors

被引：0
|
作者：
Wyatt, Gwen [1 ]
Sikorskii, Alla [1 ]
机构：
[1] Michigan State Univ, E Lansing, MI 48824 USA
来源：
PSYCHO-ONCOLOGY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：104 / 105
页数：2
相关论文
共 50 条
  • [21] Effect of treatment interruptions in prostate cancer
    Kupelian, Patrick
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (06) : 312 - 313
  • [22] SYMPTOM MANAGEMENT AND INTERRUPTIONS IN CANCER TREATMENT
    Wyatt, Gwen
    Sikorskii, Alla
    ANNALS OF BEHAVIORAL MEDICINE, 2014, 47 : S253 - S253
  • [23] THE IMPORTANCE OF TREATMENT INTERRUPTIONS IN CERVIX CANCER
    FYLES, AW
    PINTILIE, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 : 288 - 288
  • [24] Treatment interruptions in chronic HIV infection
    不详
    PLOS MEDICINE, 2004, 1 (03) : 171 - 171
  • [25] Is it smart to continue to study treatment interruptions?
    Hirschel, Bernard
    Flanigan, Timothy
    AIDS, 2009, 23 (07) : 757 - 759
  • [26] A two-bag acetylcysteine regimen is associated with shorter delays and interruptions in the treatment of paracetamol overdose
    O'Callaghan, Charlotte
    Graudins, Andis
    Wong, Anselm
    CLINICAL TOXICOLOGY, 2022, 60 (03) : 319 - 323
  • [27] Treatment interruptions and duration associated with default among new patients with tuberculosis in six regions of Russia
    Jakubowiak, W.
    Bogorodskaya, E.
    Borisov, S.
    Danilova, I.
    Kourbatova, E.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (03) : 362 - 368
  • [28] Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseases
    Lamberg, Tea
    Sipponen, Taina
    Valtanen, Sanna
    Eklund, Kari K.
    Malkonen, Tarja
    Aalto, Kristiina
    Mikola, Katriina
    Kolho, Kaija-Leena
    Leinonen, Sanna
    Isomaki, Pia
    Makinen, Heidi
    Vidqvist, Krista-Liisa
    Kokko, Arto
    Huilaja, Laura
    Kyllonen, Minna
    Keskitalo, Paula
    Sard, Sirja
    Vahasalo, Paula
    Koskela, Ritva
    Kroger, Liisa
    Lahtinen, Perttu
    Haapala, Anna-Maija
    Korkatti, Katja
    Sokka-Isler, Tuulikki
    Jokiranta, T. Sakari
    AUTOIMMUNITY, 2022, 55 (05) : 275 - 284
  • [29] Non-adherence and drug-related interruptions are risk factors for delays in completion of treatment for tuberculosis
    Pettit, A. C.
    Cummins, J.
    Kaltenbach, L. A.
    Sterling, T. R.
    Warkentin, J. V.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (04) : 486 - 492
  • [30] Polytrauma: Treatment, cost, and associated factors
    Petroudi D.
    Tsagkaris I.
    Mastrokalos D.
    Galanopoulos I.
    Galanis P.
    Papagelopoulos P.
    Kontogeorgakos V.
    Journal of Long-Term Effects of Medical Implants, 2019, 29 (04): : 311 - 316
12345